Adaptin Bio (APTN) Income from Continuing Operations (2023 - 2026)
Adaptin Bio recorded quarterly Income from Continuing Operations of 1146096.0 in Q1 2026, up 18.16% quarter-over-quarter from 1400449.0 in Q4 2025, and down 90.04% year-over-year from 11506062.06 in Q1 2025.
Adaptin Bio's Income from Continuing Operations history runs 4 years deep, the most recent figure standing at 1146096.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 90.04% year-over-year to 1146096.0; the TTM figure through Mar 2026 stood at 5743012.0 (down 69.6% YoY), while the FY2025 annual figure was 5200000.0, down 66.53% from the prior year.
- Income from Continuing Operations came in at 1146096.0 for Q1 2026 at Adaptin Bio, up from 1400449.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 34155.0 in Q4 2023 to a low of 1675612.0 in Q3 2025.
- A 4-year average of 867795.09 and a median of 856836.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations tumbled 2479.42% in 2024 and slumped 51.29% in 2025, its largest moves.
- Adaptin Bio's Income from Continuing Operations stood at 34155.0 in 2023, then sank by 2408.67% to 856836.0 in 2024, then tumbled by 63.44% to 1400449.0 in 2025, then grew by 18.16% to 1146096.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1146096.0, 1400449.0, and 1675612.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.15 Mn |
| Dec 31, 2025 | -1.37 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | -1.52 Mn |
| Mar 31, 2025 | -603,084.00 |
| Dec 31, 2024 | -856,836.00 |
| Sep 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -818,738.00 |
| Mar 31, 2024 | -339,432.00 |
| Dec 31, 2023 | -34,155.00 |
| Sep 30, 2023 | -42,938.00 |